Covid-19
Unser Engagement in der besonderen Lage (5/5) – Produktionsstandort
Our commitment in the special situation - diagnostics, medicines, vaccines
Three questions to Johanna Friedl-Naderer – President Europe, Canada & Partner Markets, Biogen
Three questions to Nicholas Franco from Johnson & Johnson